Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

BN vs MS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BN
Brookfield Corporation

Asset Management

Financial ServicesNYSE • CA
Market Cap$104.26B
5Y Perf.+172.8%
MS
Morgan Stanley

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$307.53B
5Y Perf.+337.3%

BN vs MS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BN logoBN
MS logoMS
IndustryAsset ManagementFinancial - Capital Markets
Market Cap$104.26B$307.53B
Revenue (TTM)$77.66B$103.14B
Net Income (TTM)$1.31B$16.18B
Gross Margin40.0%55.6%
Operating Margin39.9%17.1%
Forward P/E16.7x16.3x
Total Debt$263.42B$360.49B
Cash & Equiv.$16.24B$75.74B

BN vs MSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BN
MS
StockMay 20May 26Return
Brookfield Corporat… (BN)100272.8+172.8%
Morgan Stanley (MS)100437.3+337.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: BN vs MS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MS leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Brookfield Corporation is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. As sector peers, any of these can serve as alternatives in the same allocation.
BN
Brookfield Corporation
The Banking Pick

BN is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 1.57, current ratio 1.14x
  • Efficiency ratio 0.0% vs MS's 0.4% (lower = leaner)
  • Efficiency ratio 0.0% vs MS's 0.4%
Best for: sleep-well-at-night
MS
Morgan Stanley
The Banking Pick

MS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 11 yrs, beta 1.37, yield 2.0%
  • Rev growth 16.8%, EPS growth 53.5%
  • 7.4% 10Y total return vs BN's 305.3%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthMS logoMS16.8% NII/revenue growth vs BN's -9.7%
ValueMS logoMSLower P/E (16.3x vs 16.7x)
Quality / MarginsBN logoBNEfficiency ratio 0.0% vs MS's 0.4% (lower = leaner)
Stability / SafetyMS logoMSBeta 1.37 vs BN's 1.57
DividendsMS logoMS2.0% yield; 11-year raise streak; the other pay no meaningful dividend
Momentum (1Y)MS logoMS+66.7% vs BN's +28.5%
Efficiency (ROA)BN logoBNEfficiency ratio 0.0% vs MS's 0.4%

BN vs MS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BNBrookfield Corporation

Segment breakdown not available.

MSMorgan Stanley
FY 2024
Wealth Management Segment
45.6%$28.4B
Institutional Securities Segment
45.0%$28.1B
Investment Management Segment
9.4%$5.9B

BN vs MS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMSLAGGINGBN

Income & Cash Flow (Last 12 Months)

Evenly matched — BN and MS each lead in 2 of 4 comparable metrics.

MS and BN operate at a comparable scale, with $103.1B and $77.7B in trailing revenue. MS is the more profitable business, keeping 13.0% of every revenue dollar as net income compared to BN's 1.7%.

MetricBN logoBNBrookfield Corpor…MS logoMSMorgan Stanley
RevenueTrailing 12 months$77.7B$103.1B
EBITDAEarnings before interest/tax$32.1B$26.3B
Net IncomeAfter-tax profit$1.3B$16.2B
Free Cash FlowCash after capex-$2.8B-$6.7B
Gross MarginGross profit ÷ Revenue+40.0%+55.6%
Operating MarginEBIT ÷ Revenue+39.9%+17.1%
Net MarginNet income ÷ Revenue+1.7%+13.0%
FCF MarginFCF ÷ Revenue-2.0%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+73.1%+48.9%
Evenly matched — BN and MS each lead in 2 of 4 comparable metrics.

Valuation Metrics

BN leads this category, winning 3 of 5 comparable metrics.

At 24.3x trailing earnings, MS trades at a 100% valuation discount to BN's 9999.0x P/E. On an enterprise value basis, BN's 8.5x EV/EBITDA is more attractive than MS's 26.0x.

MetricBN logoBNBrookfield Corpor…MS logoMSMorgan Stanley
Market CapShares × price$104.3B$307.5B
Enterprise ValueMkt cap + debt − cash$351.4B$592.3B
Trailing P/EPrice ÷ TTM EPS9999.00x24.31x
Forward P/EPrice ÷ next-FY EPS est.16.66x16.28x
PEG RatioP/E ÷ EPS growth rate2.73x
EV / EBITDAEnterprise value multiple8.52x26.03x
Price / SalesMarket cap ÷ Revenue1.34x2.98x
Price / BookPrice ÷ Book value/share0.66x2.95x
Price / FCFMarket cap ÷ FCF
BN leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

BN leads this category, winning 6 of 8 comparable metrics.

MS delivers a 14.6% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $1 for BN. BN carries lower financial leverage with a 1.59x debt-to-equity ratio, signaling a more conservative balance sheet compared to MS's 3.42x.

MetricBN logoBNBrookfield Corpor…MS logoMSMorgan Stanley
ROE (TTM)Return on equity+0.8%+14.6%
ROA (TTM)Return on assets+0.3%+1.2%
ROICReturn on invested capital+5.6%+2.9%
ROCEReturn on capital employed+7.2%+3.8%
Piotroski ScoreFundamental quality 0–955
Debt / EquityFinancial leverage1.59x3.42x
Net DebtTotal debt minus cash$247.2B$284.7B
Cash & Equiv.Liquid assets$16.2B$75.7B
Total DebtShort + long-term debt$263.4B$360.5B
Interest CoverageEBIT ÷ Interest expense1.64x0.44x
BN leads this category, winning 6 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

MS leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in MS five years ago would be worth $24,217 today (with dividends reinvested), compared to $19,191 for BN. Over the past 12 months, MS leads with a +66.7% total return vs BN's +28.5%. The 3-year compound annual growth rate (CAGR) favors MS at 34.3% vs BN's 30.4% — a key indicator of consistent wealth creation.

MetricBN logoBNBrookfield Corpor…MS logoMSMorgan Stanley
YTD ReturnYear-to-date-0.2%+7.4%
1-Year ReturnPast 12 months+28.5%+66.7%
3-Year ReturnCumulative with dividends+121.8%+142.1%
5-Year ReturnCumulative with dividends+91.9%+142.2%
10-Year ReturnCumulative with dividends+305.3%+739.4%
CAGR (3Y)Annualised 3-year return+30.4%+34.3%
MS leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

MS leads this category, winning 2 of 2 comparable metrics.

MS is the less volatile stock with a 1.37 beta — it tends to amplify market swings less than BN's 1.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 99.2% from its 52-week high vs BN's 93.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBN logoBNBrookfield Corpor…MS logoMSMorgan Stanley
Beta (5Y)Sensitivity to S&P 5001.57x1.37x
52-Week HighHighest price in past year$49.57$194.83
52-Week LowLowest price in past year$35.95$117.21
% of 52W HighCurrent price vs 52-week peak+93.7%+99.2%
RSI (14)Momentum oscillator 0–10059.861.2
Avg Volume (50D)Average daily shares traded5.9M5.4M
MS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

MS leads this category, winning 1 of 1 comparable metric.

Wall Street rates BN as "Buy" and MS as "Buy". Consensus price targets imply 17.1% upside for BN (target: $54) vs 6.5% for MS (target: $206). MS is the only dividend payer here at 1.97% yield — a key consideration for income-focused portfolios.

MetricBN logoBNBrookfield Corpor…MS logoMSMorgan Stanley
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$54.40$205.75
# AnalystsCovering analysts952
Dividend YieldAnnual dividend ÷ price+2.0%
Dividend StreakConsecutive years of raises111
Dividend / ShareAnnual DPS$3.81
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.4%
MS leads this category, winning 1 of 1 comparable metric.
Key Takeaway

MS leads in 3 of 6 categories (Total Returns, Risk & Volatility). BN leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.

Best OverallMorgan Stanley (MS)Leads 3 of 6 categories
Loading custom metrics...

BN vs MS: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is BN or MS a better buy right now?

For growth investors, Morgan Stanley (MS) is the stronger pick with 16.

8% revenue growth year-over-year, versus -9. 7% for Brookfield Corporation (BN). Morgan Stanley (MS) offers the better valuation at 24. 3x trailing P/E (16. 3x forward), making it the more compelling value choice. Analysts rate Brookfield Corporation (BN) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — BN or MS?

On trailing P/E, Morgan Stanley (MS) is the cheapest at 24.

3x versus Brookfield Corporation at 9999. 0x. On forward P/E, Morgan Stanley is actually cheaper at 16. 3x.

03

Which is the better long-term investment — BN or MS?

Over the past 5 years, Morgan Stanley (MS) delivered a total return of +142.

2%, compared to +91. 9% for Brookfield Corporation (BN). Over 10 years, the gap is even starker: MS returned +739. 4% versus BN's +305. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — BN or MS?

By beta (market sensitivity over 5 years), Morgan Stanley (MS) is the lower-risk stock at 1.

37β versus Brookfield Corporation's 1. 57β — meaning BN is approximately 14% more volatile than MS relative to the S&P 500. On balance sheet safety, Brookfield Corporation (BN) carries a lower debt/equity ratio of 159% versus 3% for Morgan Stanley — giving it more financial flexibility in a downturn.

05

Which is growing faster — BN or MS?

By revenue growth (latest reported year), Morgan Stanley (MS) is pulling ahead at 16.

8% versus -9. 7% for Brookfield Corporation (BN). On earnings-per-share growth, the picture is similar: Morgan Stanley grew EPS 53. 5% year-over-year, compared to -99. 8% for Brookfield Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — BN or MS?

Morgan Stanley (MS) is the more profitable company, earning 13.

0% net margin versus 1. 7% for Brookfield Corporation — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BN leads at 39. 9% versus 17. 1% for MS. At the gross margin level — before operating expenses — MS leads at 55. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is BN or MS more undervalued right now?

On forward earnings alone, Morgan Stanley (MS) trades at 16.

3x forward P/E versus 16. 7x for Brookfield Corporation — 0. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BN: 17. 1% to $54. 40.

08

Which pays a better dividend — BN or MS?

In this comparison, MS (2.

0% yield) pays a dividend. BN does not pay a meaningful dividend and should not be held primarily for income.

09

Is BN or MS better for a retirement portfolio?

For long-horizon retirement investors, Morgan Stanley (MS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (2.

0% yield, +739. 4% 10Y return). Brookfield Corporation (BN) carries a higher beta of 1. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MS: +739. 4%, BN: +305. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between BN and MS?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: BN is a mid-cap quality compounder stock; MS is a large-cap high-growth stock. MS pays a dividend while BN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

BN

Quality Business

  • Sector: Financial Services
  • Market Cap > $100B
  • Gross Margin > 24%
Run This Screen
Stocks Like

MS

High-Growth Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BN and MS on the metrics below

Revenue Growth>
%
(BN: -9.7% · MS: 16.8%)
P/E Ratio<
x
(BN: 9999.0x · MS: 24.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.